summari report result close
issu outlook first time revenu
y/i organ shi estim beat consensu
estim reflect broad-bas growth across busi
divis geographi ep y/i report
came ahead consensu estim reflect
drop-through sale growth lower-effect tax rate versu
project overal strong quarterli print
deliv organ growth full year
exceed top-end guidanc rang syk
outlook call organ revenu growth rang
compar consensu estim
initi outlook appear conserv us like prudent
earli year look deliv ep
y/i bracket consensu prior estim
low-end result guidanc keep
revenu estim rel intact
impli growth y/i rais ep
estim y/i
y/i
orthoped organ sale growth y/i
impli sequenti acceler stack two-year basi
orthoped sale miss estim driven
trauma extrem compani deliv organ revenu
growth level
repres sequenti acceler stack two-year basi
result driven strong uptak compani mako
ii hip implant continu ramp alpha nail system
 report organ growth y/i led knee
versu slightli lower growth hip
versu well trauma extrem
versu orthoped sale
includ recon capit deliv robust quarter versu
despit difficult comparison sale y/i
outsid report organ growth y/i
reflect strong perform australia canada europ
continu page
compani data secur llc estim reuter
compani data secur llc estim reuter
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
continu previou page
mako see strong uptak expect continu despit competit place
mako system quarter includ us system includ us
year ago compani global instal base approxim system includ close
us mako system util approxim procedur y/i
us includ y/i mako tka procedur repres substanti uptick
sequenti note demand mako driven uniqu benefit robot
technolog avail multipl applic abil perform cementless knee notabl
see strong traction print cementless knee exit year account
 knee procedur also saw strong demand mako hip applic hip
procedur mako y/i look ahead believ mako continu drive implant share
gain hip knee manag also note expect current trend
continu anticip much impact competit time
global recon market growth look sequenti big four recon
hip knee implant compani report result make nearli
global recon market result suggest global recon market
sequenti y/i led acceler recon market driven
knee expect clariti recon market growth rate snn
report earn
medsurg adjust organ sale growth reflect modest sequenti
deceler stack two-year basi report medsurg sale came ahead
estim driven endoscopi medic off-set instrument compani
deliv organ revenu growth level reflect modest
sequenti deceler stack two-year basi report organ growth y/i
includ tough com medic versu growth driven bed
stretcher instrument busi versu driven wast manag
sterishield smoke evacu product well focus sale team split earli last year
 endoscopi growth versu driven continu growth video franchis
led camera suction irrig novadaq portfolio product outsid medsurg
y/i reflect tough y/i comp across geographi
neurotechnolog spine organ sale growth reflect acceler
sequenti stack two-year basi report segment sale miss
estim compani deliv organ revenu growth level
driven neurotech product progress acquisit us neurotech
growth versu led cmf craniomaxillofaci hemorrhag ischem stroke
product well neuro power instrument includ sonopet iq spine note
integr effort on-going anniversari acquisit quarter compani made
progress sale forc integr front deliv sequenti improv pro forma spine sale
deliv low-singl digit target full year look ahead expect acceler
growth level beyond outsid us neurotech spine deliv strong
organ growth versu driven europ emerg market
expect deliv oper margin expans ex-wmgi expect
posit includ deliv oper margin om expans
full year look ahead manag maintain outlook
om expans exclud acquisit expect close includ
manag expect deliv om expans outlook note
expect expans
metricswfconsensuswfconsensusrevenu factset wfconsensusrevenu compani report secur llc estim factset visibl alpha explicitli state consensu visibl alpha may vari base broker contribut vs actual vs medic technolog
million fiscal year end decemb neurotechnolog total gross sg oper oper incom earn incom incom net ep excl dilut share oper oper result adjust reflect new revenu recognit standard realloc sell expens sale sourc compani report secur llc estim factset stryker corpor
price target nc
price target base approxim ep estim risk
thesi includ slower procedur volum growth increas price pressur delay new
expect deliv organ sale growth high-end med-tech led broad-bas growth
across segment geographi aid execut contribut recent acquisit
incorpor michigan stryker corpor one world largest medic technolog
compani offer orthoped implant well medic surgic equip orthoped implant
account revenu medsurg divis account nearli
neurotechnolog spine account remaind compani report sale billion
